Noel Laudi

Pembrolizumab alone or with chemotherapy versus cetuximab with chemotherapy for recurrent or metastatic squamous cell carcinoma of the head and neck (KEYNOTE-048): a randomised, open-label, phase 3 study

Barbara Burtness, Kevin J. Harrington, Richard Greil et al. · The Lancet · 2019 · 3.2K citations · Full text

Medicine, Oncology, Cancer Pharmacology +11

Combination Dabrafenib and Trametinib Versus Combination Nivolumab and Ipilimumab for Patients With Advanced <i>BRAF</i>-Mutant Melanoma: The DREAMseq Trial—ECOG-ACRIN EA6134

Michael B. Atkins, Sandra J. Lee, Bartosz Chmielowski et al. · Journal of Clinical Oncology · 2022 · 439 citations · Full text

Pharmacy, Oncology, Pharmacotherapy +17

Efficacy of high-dose therapy and hematopoietic stem cell transplantation for mantle cell lymphoma

Noel Laudi, Mukta Arora, Linda J. Burns et al. · American Journal of Hematology · 2006 · 25 citations

Medicine, Hematology, Oncology +14

Long-term follow-up after autologous hematopoietic stem cell transplantation for low-grade non-Hodgkin lymphoma

Noel Laudi, Mukta Arora, Linda J. Burns et al. · Biology of Blood and Marrow Transplantation · 2005 · 24 citations · Full text

Medicine, Hematology, Oncology +15

Phase II Study of Docetaxel and Trametinib in Patients with <i>KRAS</i> Mutation Positive Recurrent Non–Small Cell Lung Cancer (NSCLC; SWOG S1507, NCT-02642042)

Shirish M. Gadgeel, Jieling Miao, Jonathan W. Riess et al. · Clinical Cancer Research · 2023 · 21 citations · Full text

Medicine, Oncology, Pharmacology +16